Trial · NCT01606709
Gene Expression Profile After Gonadotropin Releasing Hormone (GnRH) Agonist Trigger of Oocyte Maturation
NCT01606709, Phase 4, Terminated, UConn Health; results first posted 2018-11-21
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Gene Expression Profile After Gonadotropin Releasing Hormone (GnRH) Agonist Trigger of Oocyte Maturation. Trials, record NCT01606709. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01606709
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Gene Expression Profile After Gonadotropin Releasing Hormone (GnRH) Agonist Trigger of Oocyte Maturation
- NCT number
- NCT01606709
- Status
- Terminated
- Phases
- Phase 4
- Enrollment
- 7 participants, actual
- Lead sponsor
- UConn Health
- Conditions
- Endometrial Receptivity, Ovarian Hyperstimulation Syndrome
- Interventions
- GnRH agonist, hCG
- First posted
- 2012-05-28
- Last updated
- 2018-11-21
- Results first posted
- 2018-11-21
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Endometrial Gene Expression Profile | 7 days after trigger of oocyte maturation | Microarray of gene expression in the midluteal phase |
| Secondary | Quality of Life Survey After Ovarian Stimulation and GnRHa or hCG Trigger | At baseline and up to 7 days after trigger of oocyte maturation |
Source ClinicalTrials.gov
Outcomes2
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Endometrial Gene Expression Profile | 7 days after trigger of oocyte maturation | Inadequate RNA quality to completely analyze gene expression | ||
| SECONDARY | Quality of Life Survey After Ovarian Stimulation and GnRHa or hCG Trigger | At baseline and up to 7 days after trigger of oocyte maturation | Too few patients completed survey to meaningfully analyze data |
Source ClinicalTrials.gov
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | GnRH Agonist Trigger | 4 | |
| Overall Study | STARTED | hCG Trigger | 3 | |
| Overall Study | COMPLETED | GnRH Agonist Trigger | 4 | |
| Overall Study | COMPLETED | hCG Trigger | 3 | |
| Overall Study | NOT COMPLETED | GnRH Agonist Trigger | 0 | |
| Overall Study | NOT COMPLETED | hCG Trigger | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | GnRH Agonist Trigger | 0 | 4 |
| Total, all-cause mortality | hCG Trigger | 0 | 3 |
| Total, other adverse events | GnRH Agonist Trigger | 0 | 4 |
| Total, other adverse events | hCG Trigger | 0 | 3 |
| Total, serious adverse events | GnRH Agonist Trigger | 0 | 4 |
| Total, serious adverse events | hCG Trigger | 0 | 3 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons2
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| GnRH Agonist Trigger vs hCG Trigger: deaths from any cause | Trial comparisons |
| GnRH Agonist Trigger vs hCG Trigger: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01606709
GET https://conductscience.org/api/trials/v1/NCT01606709/registered